| $350M | ||
| $172M | ||
| $115M | ||
| $109M | ||
| $107M | ||
| $100M |
Buys | $1,172,974 | 1 | 2 |
Sells | $48,115,345 | 55 | 98 |
| WELLS DAVID B | director | 1 | $1.17M | 0 | $0 | $1.17M |
| Perez Garcia Andrea G | director | 0 | $0 | 1 | $97,925 | $-97,925 |
| Autor Deborah M. | Chief Policy Officer | 0 | $0 | 2 | $726,080 | $-726,080 |
| Elshenawy Mohamed | CTO | 0 | $0 | 1 | $946,260 | $-946,260 |
| Becklund Irene | PAO | 0 | $0 | 5 | $1.24M | $-1.24M |
| Carroll Patrick Harrison | Chief Medical Officer | 0 | $0 | 3 | $1.7M | $-1.7M |
| Boughton Soleil | Chief Legal Officer | 0 | $0 | 11 | $2.03M | $-2.03M |
| Chi Michael | Chief Commercial Officer | 0 | $0 | 8 | $4.46M | $-4.46M |
| Dudum Andrew | Chief Executive Officer | 0 | $0 | 2 | $12.68M | $-12.68M |
| Okupe Oluyemi | Chief Financial Officer | 0 | $0 | 22 | $24.23M | $-24.23M |
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Over the last 12 months, insiders at Hims & Hers Health, Inc. have bought $1.17M and sold $48.12M worth of Hims & Hers Health, Inc. stock.
On average, over the past 5 years, insiders at Hims & Hers Health, Inc. have bought $1.24M and sold $94.1M worth of stock each year.
Highest buying activity among insiders over the last 12 months: WELLS DAVID B (director) — $1.17M.
The last purchase of 48,400 shares for transaction amount of $1.17M was made by WELLS DAVID B (director) on 2026‑05‑26.
| 2026-09-02 | Sale | Boughton Soleil | Chief Legal Officer | 3,458 0.0015% | $28.33 | $97,965 | -3.19% | |
| 2026-08-19 | Sale | Boughton Soleil | Chief Legal Officer | 25,111 0.01% | $27.55 | $691,808 | -7.49% | |
| 2026-08-19 | Sale | Okupe Oluyemi | Chief Financial Officer | 4,938 0.0021% | $29.99 | $148,111 | -7.49% | |
| 2026-08-18 | Sale | Autor Deborah M. | Chief Policy Officer | 16,773 0.0076% | $27.85 | $467,128 | +5.29% | |
| 2026-08-17 | Sale | Okupe Oluyemi | Chief Financial Officer | 9,388 0.0039% | $27.89 | $261,802 | +0.52% | |
| 2026-07-17 | Sale | Okupe Oluyemi | Chief Financial Officer | 7,163 0.0031% | $31.99 | $229,168 | -9.93% | |
| 2026-07-06 | Sale | Okupe Oluyemi | Chief Financial Officer | 7,163 0.0031% | $36.49 | $261,351 | -19.89% | |
| 2026-06-22 | Sale | Okupe Oluyemi | Chief Financial Officer | 18,197 0.0083% | $34.03 | $619,217 | -5.64% | |
| 2026-06-18 | Sale | Okupe Oluyemi | Chief Financial Officer | 55,383 0.0246% | $35.09 | $1.94M | -10.76% | |
| 2026-06-18 | Sale | Carroll Patrick Harrison | Chief Medical Officer | 23,726 0.0105% | $35.00 | $830,410 | -10.76% | |
| 2026-06-17 | Sale | Chi Michael | Chief Operating Officer | 14,027 0.0063% | $31.50 | $441,851 | -0.72% | |
| 2026-06-17 | Sale | Elshenawy Mohamed | CTO | 30,040 0.0135% | $31.50 | $946,260 | -0.72% | |
| 2026-06-17 | Sale | Becklund Irene | PAO | 4,490 0.002% | $31.50 | $141,435 | -0.72% | |
| 2026-06-16 | Sale | Becklund Irene | PAO | 7,573 0.0033% | $30.25 | $229,083 | +0.64% | |
| 2026-05-26 | WELLS DAVID B | director | 48,400 0.0225% | $24.23 | $1.17M | +27.92% | ||
| 2026-05-18 | Sale | Okupe Oluyemi | Chief Financial Officer | 7,950 0.0038% | $23.64 | $187,916 | +34.14% | |
| 2026-04-20 | Sale | Boughton Soleil | Chief Legal Officer | 9,463 0.0042% | $30.00 | $283,890 | -6.24% | |
| 2026-04-20 | Sale | Okupe Oluyemi | Chief Financial Officer | 19,645 0.0086% | $29.96 | $588,615 | -6.24% | |
| 2026-04-17 | Sale | Okupe Oluyemi | Chief Financial Officer | 18,005 0.0079% | $27.83 | $501,158 | +1.11% | |
| 2026-04-16 | Sale | Okupe Oluyemi | Chief Financial Officer | 36,922 0.0161% | $25.90 | $956,147 | +7.73% |
| Chi Michael | Chief Operating Officer | 432124 0.1937% | $11.89M | 0 | 50 | |
| Boughton Soleil | Chief Legal Officer | 310506 0.1392% | $8.54M | 0 | 84 | |
| Okupe Oluyemi | Chief Financial Officer | 264117 0.1184% | $7.27M | 1 | 57 | +79.72% |
| WELLS DAVID B | director | 224417 0.1006% | $6.17M | 5 | 4 | <0.0001% |
| Carroll Patrick Harrison | Chief Medical Officer | 181861 0.0815% | $5M | 0 | 13 | |
| Elshenawy Mohamed | CTO | 101023 0.0453% | $2.78M | 0 | 1 | |
| Dudum Andrew | Chief Executive Officer | 95315 0.0427% | $2.62M | 2 | 58 | <0.0001% |
| Perez Garcia Andrea G | director | 80166 0.0359% | $2.21M | 0 | 1 | |
| Autor Deborah M. | Chief Policy Officer | 48961 0.0219% | $1.35M | 0 | 2 | |
| Becklund Irene | PAO | 6790 0.003% | $186,792.90 | 0 | 43 | |
| Abraham Jack | 10 percent owner | 7171203 3.2146% | $197.28M | 0 | 2 | |
| Baird Melissa | Chief Operating Officer | 805083 0.3609% | $22.15M | 0 | 63 | |
| Bard Alex | director | 227305 0.1019% | $6.25M | 0 | 4 | |
| Payne Christopher D | director | 110000 0.0493% | $3.03M | 1 | 0 | +39.98% |
| Institutional Venture Management XV, LLC | 10 percent owner | 53974 0.0242% | $1.48M | 0 | 1 | |
| Lee Spencer | Chief Financial Officer | 49893 0.0224% | $1.37M | 0 | 2 | |
| Pendarvis Christiane | director | 11417 0.0051% | $314,081.67 | 0 | 3 | |
| Manuel Anja | director | 5000 0.0022% | $137,550.00 | 2 | 0 | +88.33% |
| Maltz Jules A. | 10 percent owner | 0 0% | $0 | 2 | 3 | +68.81% |
| O'Keefe Lynne Chou | director | 0 0% | $0 | 0 | 9 |
| Increased Positions | 279 | +44.86% | 22M | +10.23% |
| Decreased Positions | 286 | -45.98% | 49M | -23% |
| New Positions | 99 | New | 4M | New |
| Sold Out Positions | 129 | Sold Out | 14M | Sold Out |
| Total Postitions | 615 | -1.13% | 185M | -12.77% |
| Blackrock, Inc. | $840,122.00 | 11.48% | 25.15M | +396,440 | +1.6% | 2025-09-30 |
| Vanguard Group Inc | $652,097.00 | 8.91% | 19.52M | +844,991 | +4.53% | 2025-09-30 |
| Capital World Investors | $627,547.00 | 8.58% | 18.78M | +223,892 | +1.21% | 2025-09-30 |
| Jpmorgan Chase & Co | $594,233.00 | 8.12% | 17.79M | +15M | +549.04% | 2025-09-30 |
| Farallon Capital Management Llc | $359,052.00 | 4.91% | 10.75M | +3M | +30.84% | 2025-09-30 |
| Goldman Sachs Group Inc | $308,158.00 | 4.21% | 9.22M | +1M | +12.99% | 2025-09-30 |
| Renaissance Technologies Llc | $303,926.00 | 4.15% | 9.1M | +2M | +32.42% | 2025-09-30 |
| Morgan Stanley | $243,094.00 | 3.32% | 7.28M | +2M | +31.6% | 2025-09-30 |
| State Street Corp | $239,657.00 | 3.28% | 7.17M | +132,384 | +1.88% | 2025-09-30 |
| Geode Capital Management, Llc | $163,736.00 | 2.24% | 4.9M | +154,733 | +3.26% | 2025-09-30 |